Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726037751?dgcid=rss_sd_all
Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S0003496726037751?dgcid=rss_sd_all
“Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights.” Annals of the Rheumatic Diseases.
@article{article36063,
title = {Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726037751?dgcid=rss_sd_all}
}